A Study of Nipocalimab in Reducing the Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) (FREESIA-1)

Project: Research project

Project Details

StatusActive
Effective start/end date8/4/251/30/30

Funding

  • Janssen Pharmaceutical Research and Development ( Award # ): $24,233.00